Shareholder Alert: Ademi LLP investigates whether PhenomeX Inc. has obtained a Fair Price in its transaction with Bruker Corporation

Provided By PR Newswire

Last update: Aug 17, 2023

MILWAUKEE, Aug. 17, 2023 /PRNewswire/ -- Ademi LLP is investigating PhenomeX (NASDAQ: CELL) for possible breaches of fiduciary duty and other violations of law in its transaction with Bruker Corporation.